Literature DB >> 17413967

Progressive herpetic linear endotheliitis.

Ying-Cheng Shen1, Chun-Yuan Wang, Yu-Chen Chen, Yi-Fen Lee.   

Abstract

PURPOSE: To report the clinical course of a rare case of bilateral herpetic linear endotheliitis.
METHODS: A 70-year-old man presented with bilateral circumferential bullous edema with stromal edema progressing centrally in the left cornea and bilateral sensorineural hearing impairment simultaneously. Serum immunoglobulin G (IgG) and IgM antibodies against herpes simplex virus type 1 (HSV1) were tested for, and aqueous humor from both eyes was examined separately using polymerase chain reaction for the presence of HSV1 DNA.
RESULTS: Serum antibody titers against HSV1 were positive. In the polymerase chain reaction, the aqueous humor showed HSV1 DNA in both eyes. Forty milligrams of prednisolone was given per day and 200 mg of oral acyclovir was given 4 times daily, but corneal edema progressed. After penetrating keratoplasty surgery in the left eye, recurrent herpetic endotheliitis also seemed to occur.
CONCLUSIONS: HSV-1 may cause bilateral corneal linear endotheliitis and hearing impairment simultaneously. Linear endotheliitis should be regarded as a manifestation of HSV1 corneal infection. There is a poor prognosis, and severe corneal edema can result if aggressive treatment is not used.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413967     DOI: 10.1097/ICO.0b013e31802c9e49

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  A diagnostic method for herpes simplex keratitis by simultaneous measurement of viral DNA and virus-specific secretory IgA in tears: an evaluation.

Authors:  Jun Shoji; Tohru Sakimoto; Noriko Inada; Yuko Kamei; Masao Matsubara; Etsuko Takamura; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2016-04-28       Impact factor: 2.447

2.  Herpes simplex virus linear endotheliitis in a post-keratoplasty patient: A case report.

Authors:  Jeongah Shin; Ho Ra; Chang Rae Rho
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.